Cargando…

GLP-1 Receptor: A New Target for Sepsis

Patients with sepsis often exhibit hyperglycemia, which increases mortality. glucagon-like peptide-1 receptor agonists (GLP-1RAs) not only regulate blood glucose homeostasis but also improve organ dysfunction, regulate immunity, and control inflammation and other functions in patients with sepsis. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fuxun, Zeng, Fan, Luo, Xiaoxiu, Lei, Yu, Li, Jiajia, Lu, Sen, Huang, Xiaobo, Lan, Yunping, Liu, Rongan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316682/ https://www.ncbi.nlm.nih.gov/pubmed/34335269 http://dx.doi.org/10.3389/fphar.2021.706908

Ejemplares similares

Resveratrol: Potential Application in Sepsis
por: Li, Jiajia, et al.
Publicado: (2022)

Potential application of ginseng in sepsis:: Applications of ginseng in sepsis
por: Yang, Fuxun, et al.
Publicado: (2023)

Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
por: Yang, Fuxun, et al.
Publicado: (2020)

Hydrogen: Potential Applications in Solid Organ Transplantation
por: Yang, Fuxun, et al.
Publicado: (2021)

Electrical Impedance Tomography Predicts Weaning Success in Adult Patients With Delayed Upper Abdominal Surgery: A Single-Center Retrospective Study
por: Li, Jiajia, et al.
Publicado: (2021)

Clinical Symptoms and Outcomes of Severe Pneumonia Caused by Chlamydia psittaci in Southwest China
por: Yang, Fuxun, et al.
Publicado: (2022)

Ferroptosis: A new therapeutic target for bladder cancer
por: Zeng, Fan, et al.
Publicado: (2022)

Comparison of COVID-19 Induced Respiratory Failure and Typical ARDS: Similarities and Differences
por: Lu, Sen, et al.
Publicado: (2022)

A case report and literature review of immune checkpoint inhibitor-associated pneumonia caused by penpulimab
por: Gao, Rongmao, et al.
Publicado: (2023)

S-thanatin functionalized liposome potentially targeting on Klebsiella pneumoniae and its application in sepsis mouse model
por: Fan, Xiaobo, et al.
Publicado: (2015)

GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
por: Pahud de Mortanges, Aurélie, et al.
Publicado: (2022)

Systematic investigation of the underlying mechanisms of GLP-1 receptor agonists to prevent myocardial infarction in patients with type 2 diabetes mellitus using network pharmacology
por: Deng, Guorong, et al.
Publicado: (2023)

Berberine influences multiple diseases by modifying gut microbiota
por: Yang, Fujie, et al.
Publicado: (2023)

GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
por: Kawanami, Daiji, et al.
Publicado: (2020)

NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells
por: Cyranka, Malgorzata, et al.
Publicado: (2022)

Microglia: A Potential Therapeutic Target for Sepsis-Associated Encephalopathy and Sepsis-Associated Chronic Pain
por: Li, Yi, et al.
Publicado: (2020)

GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress
por: Jiang, Yaojing, et al.
Publicado: (2018)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages
por: Whitley, Heather P., et al.
Publicado: (2023)

Employment intention and career planning of male nursing students in different levels of colleges and universities: A qualitative study
por: Zeng, Xiaoting, et al.
Publicado: (2023)

The Efficacy and Safety of the Combination Therapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
por: Li, Chen, et al.
Publicado: (2022)

Berberine enhances the function of db/db mice islet β cell through GLP-1/GLP-1R/PKA signaling pathway in intestinal L cell and islet α cell
por: Wu, Wenbin, et al.
Publicado: (2023)

GLP-1 Receptor Activation Abrogates β-Cell Dysfunction by PKA Cα-Mediated Degradation of Thioredoxin Interacting Protein
por: He, Shijun, et al.
Publicado: (2019)

GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS
por: Yang, Zheng, et al.
Publicado: (2022)

TFEB Dependent Autophagy-Lysosomal Pathway: An Emerging Pharmacological Target in Sepsis
por: Liu, Xin, et al.
Publicado: (2021)

Targeting Neutrophils in Sepsis: From Mechanism to Translation
por: Shen, Xiaofei, et al.
Publicado: (2021)

Molecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review
por: Zhang, Fuxun, et al.
Publicado: (2021)

Targeting Orphan Nuclear Receptors NR4As for Energy Homeostasis and Diabetes
por: Zhang, Chenyang, et al.
Publicado: (2020)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

Targeting Purinergic Signaling in the Dynamics of Disease Progression in Sepsis
por: Leite-Aguiar, Raíssa, et al.
Publicado: (2021)

Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway
por: Tong, Guoxiang, et al.
Publicado: (2022)

Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
por: Kong, Fanjing, et al.
Publicado: (2023)

Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas
por: Zhan, Xianquan, et al.
Publicado: (2021)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: She, Jianglian, et al.
Publicado: (2022)

Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
por: Hümmeke-Oppers, Femke, et al.
Publicado: (2019)

Single-cell transcriptomics reveals immune infiltrate in sepsis
por: Tu, Xusheng, et al.
Publicado: (2023)

Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
por: Kang, Yan, et al.
Publicado: (2022)

Characteristics of WBN/Kob diabetic fatty rats supplemented with a fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor agonist
por: NAMEKAWA, Junichi, et al.
Publicado: (2018)

Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes
por: Lang, Shan, et al.
Publicado: (2020)

Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway
por: Nuamnaichati, Narawat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_79rbpmof4a1ke6qqegug1ndntu